Evidence map›Paper›PMID 38940897›Full record

ArticleDermatology and therapy2024

Psoriasis and Sleep Disturbance: A US Population-Based Study Using the NHANES Database.

Payton Smith, Joy Q Jin, Riley K Spencer, Kareem G Elhage, Chandler E Johnson, Kathryn Haran, Allison Kranyak, Mitchell S Davis, Marwa Hakimi, Aric A Prather and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Molecular Link Between Psoriasis and Depression-Update on Pathophysiology.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Payton Smith *Department of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA. payton.smith@ucsf.edu.ORCID http://orcid.org/0000-0001-6505-9773
Joy Q Jin *Department of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0002-1283-4665
Riley K SpencerDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0002-7047-5146
Kareem G ElhageDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0002-2637-9341
Chandler E JohnsonDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0009-0000-5818-8710
Kathryn HaranDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0001-8166-4826
Allison KranyakDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0003-0017-138X
Mitchell S DavisDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0001-5658-5034
Marwa HakimiDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0003-0220-1909
Aric A PratherDepartment of Psychiatry and Behavioral Sciences, University of California at San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-1302-8283
Katie L StoneCalifornia Pacific Medical Center Research Institute, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-2797-3171
Wilson LiaoDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0001-7883-6439
Tina BhutaniDepartment of Dermatology, University of California at San Francisco, 2340 Sutter St., Box 0808, Floor 04, Room N426, San Francisco, CA, 94115, USA.ORCID http://orcid.org/0000-0001-8187-1024

Funding

Examining the reciprocal effects of racial discrimination and sleep on cardiovascular functioning: An experimental approachR01HL142051 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRATHER, ARIC ANDREW · 2018 to 2022
$3.5M
NHLBI NIH HHS R01 HL142051
6 · The paper itself

Abstract

introductionPsoriasis, a chronic inflammatory skin condition, affects approximately 3.0% of the US population, with patients often experiencing significant sleep disturbances. These disturbances include a higher prevalence of conditions such as obstructive sleep apnea, restless leg syndrome, and insomnia. Given the additional risks for cardiovascular disease, metabolic disorders, and depression linked to both poor sleep and psoriasis, addressing sleep issues in this patient group is critical.

methodsThe study utilized National Health and Nutrition Examination Survey (NHANES) data, focusing on individuals aged ≥ 20 years who provided information on psoriasis status and sleep. Multistage stratified survey methodology was applied, with multivariable logistic regression models used to examine the association between psoriasis and sleep issues, adjusting for factors such as age, gender, and health history.

resultsPsoriasis diagnosis was significantly associated with trouble sleeping (adjusted odds ratio [aOR] 1.88; 95% confidence interval [CI] 1.44-2.45). There was no significant association between psoriasis and sleep quantity. Older age, female gender, and a history of sleep disorders were predictors of trouble sleeping among psoriasis patients.

conclusionsPsoriasis is significantly associated with sleep disturbances, independent of sleep duration. This underscores the need for clinical screening focusing on sleep quality rather than quantity in psoriasis patients to effectively identify and treat sleep-related comorbidities. Further research using objective sleep measures is warranted to guide clinical management and improve patient quality of life.

Indexed as

ComorbiditiesDermatologyPsoriasisScreeningSleep qualitySleep quantity

Identifiers

PMID38940897
PMCPMC11333390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.